Global Large Molecule Drugs CDMO Supply, Demand and Key Producers, 2024-2030

February 2024 | 127 pages | ID: GACEB91EE81EEN
GlobalInfoResearch

Abstracts

The global Large Molecule Drugs CDMO market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

This report studies the global Large Molecule Drugs CDMO demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Large Molecule Drugs CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Large Molecule Drugs CDMO that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Large Molecule Drugs CDMO total market, 2019-2030, (USD Million)

Global Large Molecule Drugs CDMO total market by region & country, CAGR, 2019-2030, (USD Million)

U.S. VS China: Large Molecule Drugs CDMO total market, key domestic companies and share, (USD Million)

Global Large Molecule Drugs CDMO revenue by player and market share 2019-2024, (USD Million)

Global Large Molecule Drugs CDMO total market by Type, CAGR, 2019-2030, (USD Million)

Global Large Molecule Drugs CDMO total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Large Molecule Drugs CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Patheon, Eurofins Scientific, Samsung Biologics, Catalent, Inc., Rentschler Biopharma SE, AGC Biologics, Recipharm AB, Siegfried Holding AG and FUJIFILM Diosynth Biotechnologies, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Large Molecule Drugs CDMO market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Large Molecule Drugs CDMO Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Large Molecule Drugs CDMO Market, Segmentation by Type

• Cell Line Development
• Large Molecule Drug Substance Development

Global Large Molecule Drugs CDMO Market, Segmentation by Application

• Biological Technology
• Clinical
• Pharmaceutical
• Others

Companies Profiled:

• Patheon
• Eurofins Scientific
• Samsung Biologics
• Catalent, Inc.
• Rentschler Biopharma SE
• AGC Biologics
• Recipharm AB
• Siegfried Holding AG
• FUJIFILM Diosynth Biotechnologies
• Scorpius
• Ardena
• Alcami
• Cytiva
• Thermo Fisher Scientific

Key Questions Answered

1. How big is the global Large Molecule Drugs CDMO market?

2. What is the demand of the global Large Molecule Drugs CDMO market?

3. What is the year over year growth of the global Large Molecule Drugs CDMO market?

4. What is the total value of the global Large Molecule Drugs CDMO market?

5. Who are the major players in the global Large Molecule Drugs CDMO market?

Contents

1 SUPPLY SUMMARY

1.1 Large Molecule Drugs CDMO Introduction
1.2 World Large Molecule Drugs CDMO Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Large Molecule Drugs CDMO Total Market by Region (by Headquarter Location)
  1.3.1 World Large Molecule Drugs CDMO Market Size by Region (2019-2030), (by Headquarter Location)
  1.3.2 United States Large Molecule Drugs CDMO Market Size (2019-2030)
  1.3.3 China Large Molecule Drugs CDMO Market Size (2019-2030)
  1.3.4 Europe Large Molecule Drugs CDMO Market Size (2019-2030)
  1.3.5 Japan Large Molecule Drugs CDMO Market Size (2019-2030)
  1.3.6 South Korea Large Molecule Drugs CDMO Market Size (2019-2030)
  1.3.7 ASEAN Large Molecule Drugs CDMO Market Size (2019-2030)
  1.3.8 India Large Molecule Drugs CDMO Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Large Molecule Drugs CDMO Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Large Molecule Drugs CDMO Major Market Trends

2 DEMAND SUMMARY

2.1 World Large Molecule Drugs CDMO Consumption Value (2019-2030)
2.2 World Large Molecule Drugs CDMO Consumption Value by Region
  2.2.1 World Large Molecule Drugs CDMO Consumption Value by Region (2019-2024)
  2.2.2 World Large Molecule Drugs CDMO Consumption Value Forecast by Region (2025-2030)
2.3 United States Large Molecule Drugs CDMO Consumption Value (2019-2030)
2.4 China Large Molecule Drugs CDMO Consumption Value (2019-2030)
2.5 Europe Large Molecule Drugs CDMO Consumption Value (2019-2030)
2.6 Japan Large Molecule Drugs CDMO Consumption Value (2019-2030)
2.7 South Korea Large Molecule Drugs CDMO Consumption Value (2019-2030)
2.8 ASEAN Large Molecule Drugs CDMO Consumption Value (2019-2030)
2.9 India Large Molecule Drugs CDMO Consumption Value (2019-2030)

3 WORLD LARGE MOLECULE DRUGS CDMO COMPANIES COMPETITIVE ANALYSIS

3.1 World Large Molecule Drugs CDMO Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Large Molecule Drugs CDMO Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Large Molecule Drugs CDMO in 2023
  3.2.3 Global Concentration Ratios (CR8) for Large Molecule Drugs CDMO in 2023
3.3 Large Molecule Drugs CDMO Company Evaluation Quadrant
3.4 Large Molecule Drugs CDMO Market: Overall Company Footprint Analysis
  3.4.1 Large Molecule Drugs CDMO Market: Region Footprint
  3.4.2 Large Molecule Drugs CDMO Market: Company Product Type Footprint
  3.4.3 Large Molecule Drugs CDMO Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Large Molecule Drugs CDMO Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Large Molecule Drugs CDMO Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
  4.1.2 United States VS China: Large Molecule Drugs CDMO Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Large Molecule Drugs CDMO Consumption Value Comparison
  4.2.1 United States VS China: Large Molecule Drugs CDMO Consumption Value Comparison (2019 & 2023 & 2030)
  4.2.2 United States VS China: Large Molecule Drugs CDMO Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Large Molecule Drugs CDMO Companies and Market Share, 2019-2024
  4.3.1 United States Based Large Molecule Drugs CDMO Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Large Molecule Drugs CDMO Revenue, (2019-2024)
4.4 China Based Companies Large Molecule Drugs CDMO Revenue and Market Share, 2019-2024
  4.4.1 China Based Large Molecule Drugs CDMO Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Large Molecule Drugs CDMO Revenue, (2019-2024)
4.5 Rest of World Based Large Molecule Drugs CDMO Companies and Market Share, 2019-2024
  4.5.1 Rest of World Based Large Molecule Drugs CDMO Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Large Molecule Drugs CDMO Revenue, (2019-2024)

5 MARKET ANALYSIS BY TYPE

5.1 World Large Molecule Drugs CDMO Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
  5.2.1 Cell Line Development
  5.2.2 Large Molecule Drug Substance Development
5.3 Market Segment by Type
  5.3.1 World Large Molecule Drugs CDMO Market Size by Type (2019-2024)
  5.3.2 World Large Molecule Drugs CDMO Market Size by Type (2025-2030)
  5.3.3 World Large Molecule Drugs CDMO Market Size Market Share by Type (2019-2030)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Large Molecule Drugs CDMO Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
  6.2.1 Biological Technology
  6.2.2 Clinical
  6.2.3 Pharmaceutical
  6.2.4 Others
  6.2.5 Others
6.3 Market Segment by Application
  6.3.1 World Large Molecule Drugs CDMO Market Size by Application (2019-2024)
  6.3.2 World Large Molecule Drugs CDMO Market Size by Application (2025-2030)
  6.3.3 World Large Molecule Drugs CDMO Market Size by Application (2019-2030)

7 COMPANY PROFILES

7.1 Patheon
  7.1.1 Patheon Details
  7.1.2 Patheon Major Business
  7.1.3 Patheon Large Molecule Drugs CDMO Product and Services
  7.1.4 Patheon Large Molecule Drugs CDMO Revenue, Gross Margin and Market Share (2019-2024)
  7.1.5 Patheon Recent Developments/Updates
  7.1.6 Patheon Competitive Strengths & Weaknesses
7.2 Eurofins Scientific
  7.2.1 Eurofins Scientific Details
  7.2.2 Eurofins Scientific Major Business
  7.2.3 Eurofins Scientific Large Molecule Drugs CDMO Product and Services
  7.2.4 Eurofins Scientific Large Molecule Drugs CDMO Revenue, Gross Margin and Market Share (2019-2024)
  7.2.5 Eurofins Scientific Recent Developments/Updates
  7.2.6 Eurofins Scientific Competitive Strengths & Weaknesses
7.3 Samsung Biologics
  7.3.1 Samsung Biologics Details
  7.3.2 Samsung Biologics Major Business
  7.3.3 Samsung Biologics Large Molecule Drugs CDMO Product and Services
  7.3.4 Samsung Biologics Large Molecule Drugs CDMO Revenue, Gross Margin and Market Share (2019-2024)
  7.3.5 Samsung Biologics Recent Developments/Updates
  7.3.6 Samsung Biologics Competitive Strengths & Weaknesses
7.4 Catalent, Inc.
  7.4.1 Catalent, Inc. Details
  7.4.2 Catalent, Inc. Major Business
  7.4.3 Catalent, Inc. Large Molecule Drugs CDMO Product and Services
  7.4.4 Catalent, Inc. Large Molecule Drugs CDMO Revenue, Gross Margin and Market Share (2019-2024)
  7.4.5 Catalent, Inc. Recent Developments/Updates
  7.4.6 Catalent, Inc. Competitive Strengths & Weaknesses
7.5 Rentschler Biopharma SE
  7.5.1 Rentschler Biopharma SE Details
  7.5.2 Rentschler Biopharma SE Major Business
  7.5.3 Rentschler Biopharma SE Large Molecule Drugs CDMO Product and Services
  7.5.4 Rentschler Biopharma SE Large Molecule Drugs CDMO Revenue, Gross Margin and Market Share (2019-2024)
  7.5.5 Rentschler Biopharma SE Recent Developments/Updates
  7.5.6 Rentschler Biopharma SE Competitive Strengths & Weaknesses
7.6 AGC Biologics
  7.6.1 AGC Biologics Details
  7.6.2 AGC Biologics Major Business
  7.6.3 AGC Biologics Large Molecule Drugs CDMO Product and Services
  7.6.4 AGC Biologics Large Molecule Drugs CDMO Revenue, Gross Margin and Market Share (2019-2024)
  7.6.5 AGC Biologics Recent Developments/Updates
  7.6.6 AGC Biologics Competitive Strengths & Weaknesses
7.7 Recipharm AB
  7.7.1 Recipharm AB Details
  7.7.2 Recipharm AB Major Business
  7.7.3 Recipharm AB Large Molecule Drugs CDMO Product and Services
  7.7.4 Recipharm AB Large Molecule Drugs CDMO Revenue, Gross Margin and Market Share (2019-2024)
  7.7.5 Recipharm AB Recent Developments/Updates
  7.7.6 Recipharm AB Competitive Strengths & Weaknesses
7.8 Siegfried Holding AG
  7.8.1 Siegfried Holding AG Details
  7.8.2 Siegfried Holding AG Major Business
  7.8.3 Siegfried Holding AG Large Molecule Drugs CDMO Product and Services
  7.8.4 Siegfried Holding AG Large Molecule Drugs CDMO Revenue, Gross Margin and Market Share (2019-2024)
  7.8.5 Siegfried Holding AG Recent Developments/Updates
  7.8.6 Siegfried Holding AG Competitive Strengths & Weaknesses
7.9 FUJIFILM Diosynth Biotechnologies
  7.9.1 FUJIFILM Diosynth Biotechnologies Details
  7.9.2 FUJIFILM Diosynth Biotechnologies Major Business
  7.9.3 FUJIFILM Diosynth Biotechnologies Large Molecule Drugs CDMO Product and Services
  7.9.4 FUJIFILM Diosynth Biotechnologies Large Molecule Drugs CDMO Revenue, Gross Margin and Market Share (2019-2024)
  7.9.5 FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
  7.9.6 FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
7.10 Scorpius
  7.10.1 Scorpius Details
  7.10.2 Scorpius Major Business
  7.10.3 Scorpius Large Molecule Drugs CDMO Product and Services
  7.10.4 Scorpius Large Molecule Drugs CDMO Revenue, Gross Margin and Market Share (2019-2024)
  7.10.5 Scorpius Recent Developments/Updates
  7.10.6 Scorpius Competitive Strengths & Weaknesses
7.11 Ardena
  7.11.1 Ardena Details
  7.11.2 Ardena Major Business
  7.11.3 Ardena Large Molecule Drugs CDMO Product and Services
  7.11.4 Ardena Large Molecule Drugs CDMO Revenue, Gross Margin and Market Share (2019-2024)
  7.11.5 Ardena Recent Developments/Updates
  7.11.6 Ardena Competitive Strengths & Weaknesses
7.12 Alcami
  7.12.1 Alcami Details
  7.12.2 Alcami Major Business
  7.12.3 Alcami Large Molecule Drugs CDMO Product and Services
  7.12.4 Alcami Large Molecule Drugs CDMO Revenue, Gross Margin and Market Share (2019-2024)
  7.12.5 Alcami Recent Developments/Updates
  7.12.6 Alcami Competitive Strengths & Weaknesses
7.13 Cytiva
  7.13.1 Cytiva Details
  7.13.2 Cytiva Major Business
  7.13.3 Cytiva Large Molecule Drugs CDMO Product and Services
  7.13.4 Cytiva Large Molecule Drugs CDMO Revenue, Gross Margin and Market Share (2019-2024)
  7.13.5 Cytiva Recent Developments/Updates
  7.13.6 Cytiva Competitive Strengths & Weaknesses
7.14 Thermo Fisher Scientific
  7.14.1 Thermo Fisher Scientific Details
  7.14.2 Thermo Fisher Scientific Major Business
  7.14.3 Thermo Fisher Scientific Large Molecule Drugs CDMO Product and Services
  7.14.4 Thermo Fisher Scientific Large Molecule Drugs CDMO Revenue, Gross Margin and Market Share (2019-2024)
  7.14.5 Thermo Fisher Scientific Recent Developments/Updates
  7.14.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Large Molecule Drugs CDMO Industry Chain
8.2 Large Molecule Drugs CDMO Upstream Analysis
8.3 Large Molecule Drugs CDMO Midstream Analysis
8.4 Large Molecule Drugs CDMO Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Large Molecule Drugs CDMO Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Large Molecule Drugs CDMO Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Large Molecule Drugs CDMO Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Large Molecule Drugs CDMO Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Large Molecule Drugs CDMO Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Large Molecule Drugs CDMO Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Large Molecule Drugs CDMO Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Large Molecule Drugs CDMO Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Large Molecule Drugs CDMO Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Large Molecule Drugs CDMO Players in 2023
Table 12. World Large Molecule Drugs CDMO Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Large Molecule Drugs CDMO Company Evaluation Quadrant
Table 14. Head Office of Key Large Molecule Drugs CDMO Player
Table 15. Large Molecule Drugs CDMO Market: Company Product Type Footprint
Table 16. Large Molecule Drugs CDMO Market: Company Product Application Footprint
Table 17. Large Molecule Drugs CDMO Mergers & Acquisitions Activity
Table 18. United States VS China Large Molecule Drugs CDMO Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Large Molecule Drugs CDMO Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Large Molecule Drugs CDMO Companies, Headquarters (States, Country)
Table 21. United States Based Companies Large Molecule Drugs CDMO Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Large Molecule Drugs CDMO Revenue Market Share (2019-2024)
Table 23. China Based Large Molecule Drugs CDMO Companies, Headquarters (Province, Country)
Table 24. China Based Companies Large Molecule Drugs CDMO Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Large Molecule Drugs CDMO Revenue Market Share (2019-2024)
Table 26. Rest of World Based Large Molecule Drugs CDMO Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Large Molecule Drugs CDMO Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Large Molecule Drugs CDMO Revenue Market Share (2019-2024)
Table 29. World Large Molecule Drugs CDMO Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Large Molecule Drugs CDMO Market Size by Type (2019-2024) & (USD Million)
Table 31. World Large Molecule Drugs CDMO Market Size by Type (2025-2030) & (USD Million)
Table 32. World Large Molecule Drugs CDMO Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Large Molecule Drugs CDMO Market Size by Application (2019-2024) & (USD Million)
Table 34. World Large Molecule Drugs CDMO Market Size by Application (2025-2030) & (USD Million)
Table 35. Patheon Basic Information, Area Served and Competitors
Table 36. Patheon Major Business
Table 37. Patheon Large Molecule Drugs CDMO Product and Services
Table 38. Patheon Large Molecule Drugs CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Patheon Recent Developments/Updates
Table 40. Patheon Competitive Strengths & Weaknesses
Table 41. Eurofins Scientific Basic Information, Area Served and Competitors
Table 42. Eurofins Scientific Major Business
Table 43. Eurofins Scientific Large Molecule Drugs CDMO Product and Services
Table 44. Eurofins Scientific Large Molecule Drugs CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Eurofins Scientific Recent Developments/Updates
Table 46. Eurofins Scientific Competitive Strengths & Weaknesses
Table 47. Samsung Biologics Basic Information, Area Served and Competitors
Table 48. Samsung Biologics Major Business
Table 49. Samsung Biologics Large Molecule Drugs CDMO Product and Services
Table 50. Samsung Biologics Large Molecule Drugs CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Samsung Biologics Recent Developments/Updates
Table 52. Samsung Biologics Competitive Strengths & Weaknesses
Table 53. Catalent, Inc. Basic Information, Area Served and Competitors
Table 54. Catalent, Inc. Major Business
Table 55. Catalent, Inc. Large Molecule Drugs CDMO Product and Services
Table 56. Catalent, Inc. Large Molecule Drugs CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. Catalent, Inc. Recent Developments/Updates
Table 58. Catalent, Inc. Competitive Strengths & Weaknesses
Table 59. Rentschler Biopharma SE Basic Information, Area Served and Competitors
Table 60. Rentschler Biopharma SE Major Business
Table 61. Rentschler Biopharma SE Large Molecule Drugs CDMO Product and Services
Table 62. Rentschler Biopharma SE Large Molecule Drugs CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Rentschler Biopharma SE Recent Developments/Updates
Table 64. Rentschler Biopharma SE Competitive Strengths & Weaknesses
Table 65. AGC Biologics Basic Information, Area Served and Competitors
Table 66. AGC Biologics Major Business
Table 67. AGC Biologics Large Molecule Drugs CDMO Product and Services
Table 68. AGC Biologics Large Molecule Drugs CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. AGC Biologics Recent Developments/Updates
Table 70. AGC Biologics Competitive Strengths & Weaknesses
Table 71. Recipharm AB Basic Information, Area Served and Competitors
Table 72. Recipharm AB Major Business
Table 73. Recipharm AB Large Molecule Drugs CDMO Product and Services
Table 74. Recipharm AB Large Molecule Drugs CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Recipharm AB Recent Developments/Updates
Table 76. Recipharm AB Competitive Strengths & Weaknesses
Table 77. Siegfried Holding AG Basic Information, Area Served and Competitors
Table 78. Siegfried Holding AG Major Business
Table 79. Siegfried Holding AG Large Molecule Drugs CDMO Product and Services
Table 80. Siegfried Holding AG Large Molecule Drugs CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Siegfried Holding AG Recent Developments/Updates
Table 82. Siegfried Holding AG Competitive Strengths & Weaknesses
Table 83. FUJIFILM Diosynth Biotechnologies Basic Information, Area Served and Competitors
Table 84. FUJIFILM Diosynth Biotechnologies Major Business
Table 85. FUJIFILM Diosynth Biotechnologies Large Molecule Drugs CDMO Product and Services
Table 86. FUJIFILM Diosynth Biotechnologies Large Molecule Drugs CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
Table 88. FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
Table 89. Scorpius Basic Information, Area Served and Competitors
Table 90. Scorpius Major Business
Table 91. Scorpius Large Molecule Drugs CDMO Product and Services
Table 92. Scorpius Large Molecule Drugs CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. Scorpius Recent Developments/Updates
Table 94. Scorpius Competitive Strengths & Weaknesses
Table 95. Ardena Basic Information, Area Served and Competitors
Table 96. Ardena Major Business
Table 97. Ardena Large Molecule Drugs CDMO Product and Services
Table 98. Ardena Large Molecule Drugs CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. Ardena Recent Developments/Updates
Table 100. Ardena Competitive Strengths & Weaknesses
Table 101. Alcami Basic Information, Area Served and Competitors
Table 102. Alcami Major Business
Table 103. Alcami Large Molecule Drugs CDMO Product and Services
Table 104. Alcami Large Molecule Drugs CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 105. Alcami Recent Developments/Updates
Table 106. Alcami Competitive Strengths & Weaknesses
Table 107. Cytiva Basic Information, Area Served and Competitors
Table 108. Cytiva Major Business
Table 109. Cytiva Large Molecule Drugs CDMO Product and Services
Table 110. Cytiva Large Molecule Drugs CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 111. Cytiva Recent Developments/Updates
Table 112. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 113. Thermo Fisher Scientific Major Business
Table 114. Thermo Fisher Scientific Large Molecule Drugs CDMO Product and Services
Table 115. Thermo Fisher Scientific Large Molecule Drugs CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 116. Global Key Players of Large Molecule Drugs CDMO Upstream (Raw Materials)
Table 117. Large Molecule Drugs CDMO Typical Customers

LIST OF FIGURE

Figure 1. Large Molecule Drugs CDMO Picture
Figure 2. World Large Molecule Drugs CDMO Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Large Molecule Drugs CDMO Total Market Size (2019-2030) & (USD Million)
Figure 4. World Large Molecule Drugs CDMO Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Large Molecule Drugs CDMO Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Large Molecule Drugs CDMO Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Large Molecule Drugs CDMO Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Large Molecule Drugs CDMO Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Large Molecule Drugs CDMO Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Large Molecule Drugs CDMO Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Large Molecule Drugs CDMO Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Large Molecule Drugs CDMO Revenue (2019-2030) & (USD Million)
Figure 13. Large Molecule Drugs CDMO Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Large Molecule Drugs CDMO Consumption Value (2019-2030) & (USD Million)
Figure 16. World Large Molecule Drugs CDMO Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Large Molecule Drugs CDMO Consumption Value (2019-2030) & (USD Million)
Figure 18. China Large Molecule Drugs CDMO Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Large Molecule Drugs CDMO Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Large Molecule Drugs CDMO Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Large Molecule Drugs CDMO Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Large Molecule Drugs CDMO Consumption Value (2019-2030) & (USD Million)
Figure 23. India Large Molecule Drugs CDMO Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Large Molecule Drugs CDMO by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Large Molecule Drugs CDMO Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Large Molecule Drugs CDMO Markets in 2023
Figure 27. United States VS China: Large Molecule Drugs CDMO Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Large Molecule Drugs CDMO Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Large Molecule Drugs CDMO Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Large Molecule Drugs CDMO Market Size Market Share by Type in 2023
Figure 31. Cell Line Development
Figure 32. Large Molecule Drug Substance Development
Figure 33. World Large Molecule Drugs CDMO Market Size Market Share by Type (2019-2030)
Figure 34. World Large Molecule Drugs CDMO Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 35. World Large Molecule Drugs CDMO Market Size Market Share by Application in 2023
Figure 36. Biological Technology
Figure 37. Clinical
Figure 38. Pharmaceutical
Figure 39. Others
Figure 40. Large Molecule Drugs CDMO Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source